These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11702111)

  • 1. Initial investigations of 99mTc-labeled morpholinos for radiopharmaceutical applications.
    Mang'era KO; Liu G; Yi W; Zhang Y; Liu N; Gupta S; Rusckowski M; Hnatowich DJ
    Eur J Nucl Med; 2001 Nov; 28(11):1682-9. PubMed ID: 11702111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of in vitro and in vivo stability in mice of two morpholino duplexes differing in chain length.
    He J; Liu G; Zhang S; Vanderheyden JL; Liu N; Liu C; Zhang Y; Gupta S; Rusckowski M; Hnatowich DJ
    Bioconjug Chem; 2003; 14(5):1018-23. PubMed ID: 13129406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo hybridization of technetium-99m-labeled peptide nucleic acid (PNA).
    Mardirossian G; Lei K; Rusckowski M; Chang F; Qu T; Egholm M; Hnatowich DJ
    J Nucl Med; 1997 Jun; 38(6):907-13. PubMed ID: 9189140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Affinity enhancement pretargeting: synthesis and testing of a 99mTc-labeled bivalent MORF.
    He J; Wang Y; Dou S; Liu X; Zhang S; Liu G; Hnatowich D
    Mol Pharm; 2010 Aug; 7(4):1118-24. PubMed ID: 20507096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor pretargeting in mice using (99m)Tc-labeled morpholino, a DNA analog.
    Liu G; Mang'era K; Liu N; Gupta S; Rusckowski M; Hnatowich DJ
    J Nucl Med; 2002 Mar; 43(3):384-91. PubMed ID: 11884499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics in mice of four oligomer-conjugated polymers for amplification targeting.
    He J; Liu G; Zhang S; Rusckowski M; Hnatowich DJ
    Cancer Biother Radiopharm; 2003 Dec; 18(6):941-7. PubMed ID: 14969606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiolabeling morpholinos with 90Y, 111In, 188Re and 99mTc.
    Liu CB; Liu GZ; Liu N; Zhang YM; He J; Rusckowski M; Hnatowich DJ
    Nucl Med Biol; 2003 Feb; 30(2):207-14. PubMed ID: 12623121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretargeting in tumored mice with radiolabeled morpholino oligomer showing low kidney uptake.
    Liu G; He J; Dou S; Gupta S; Vanderheyden JL; Rusckowski M; Hnatowich DJ
    Eur J Nucl Med Mol Imaging; 2004 Mar; 31(3):417-24. PubMed ID: 14691611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amplification targeting: a modified pretargeting approach with potential for signal amplification-proof of a concept.
    He J; Liu G; Gupta S; Zhang Y; Rusckowski M; Hnatowich DJ
    J Nucl Med; 2004 Jun; 45(6):1087-95. PubMed ID: 15181145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An improved method for covalently conjugating morpholino oligomers to antitumor antibodies.
    He J; Liu G; Dou S; Gupta S; Rusckowski M; Hnatowich D
    Bioconjug Chem; 2007; 18(3):983-8. PubMed ID: 17385902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting the biodistribution of radiolabeled cMORF effector in MORF-pretargeted mice.
    Liu G; Dou S; He J; Liu X; Rusckowski M; Hnatowich DJ
    Eur J Nucl Med Mol Imaging; 2007 Feb; 34(2):237-46. PubMed ID: 17021815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Affinity enhancement bivalent morpholino for pretargeting: initial evidence by surface plasmon resonance.
    He J; Liu G; Vanderheyden JL; Dou S; Mary R; Hnatowich DJ
    Bioconjug Chem; 2005; 16(2):338-45. PubMed ID: 15769087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiolabeling of MAG3-morpholino oligomers with 188Re at high labeling efficiency and specific radioactivity for tumor pretargeting.
    Liu G; Dou S; He J; Yin D; Gupta S; Zhang S; Wang Y; Rusckowski M; Hnatowich DJ
    Appl Radiat Isot; 2006 Sep; 64(9):971-8. PubMed ID: 16730997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiolabelling morpholinos with 188Re tricarbonyl provides improved in vitro and in vivo stability to re-oxidation.
    He J; Liu C; Vanderheyden JL; Liu G; Dou S; Rusckowski M; Hnatowich DJ
    Nucl Med Commun; 2004 Jul; 25(7):731-6. PubMed ID: 15208502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replacing 99mTc with 111In improves MORF/cMORF pretargeting by reducing intestinal accumulation.
    Liu G; Cheng D; Dou S; Chen X; Liang M; Pretorius PH; Rusckowski M; Hnatowich DJ
    Mol Imaging Biol; 2009; 11(5):303-7. PubMed ID: 19326173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simplified preparation via streptavidin of antisense oligomers/carriers nanoparticles showing improved cellular delivery in culture.
    Wang Y; Nakamura K; Liu X; Kitamura N; Kubo A; Hnatowich DJ
    Bioconjug Chem; 2007; 18(4):1338-43. PubMed ID: 17605463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further investigations of morpholino pretargeting in mice--establishing quantitative relations in tumor.
    Liu G; He J; Dou S; Gupta S; Rusckowski M; Hnatowich DJ
    Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1115-23. PubMed ID: 16133391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytosine residues influence kidney accumulations of 99mTc-labeled morpholino oligomers.
    Liu G; He J; Zhang S; Liu C; Rusckowski M; Hnatowich DJ
    Antisense Nucleic Acid Drug Dev; 2002 Dec; 12(6):393-8. PubMed ID: 12568313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optical pretargeting of tumor with fluorescent MORF oligomers.
    He J; Rusckowski M; Wang Y; Dou S; Liu X; Zhang S; Liu G; Hnatowich DJ
    Mol Imaging Biol; 2007; 9(1):17-23. PubMed ID: 17171474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigations of 99mTc morpholino pretargeting in mice.
    Liu G; Liu C; Zhang S; He J; Liu N; Gupta S; Rusckowski M; Hnatowich DJ
    Nucl Med Commun; 2003 Jun; 24(6):697-705. PubMed ID: 12766607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.